Pancytopenia during tyrosine kinase inhibitor treatment – coexistence of chronic myeloid leukemia and visceral leishmaniasis: a case report-Reference-Cited by-同舟云学术

Pancytopenia during tyrosine kinase inhibitor treatment – coexistence of chronic myeloid leukemia and visceral leishmaniasis: a case report

Published:2016-07-27 Issue:1 Volume:10 Page:
ISSN:1752-1947
Container-title:Journal of Medical Case Reports
language:en
Short-container-title:J Med Case Reports

Author:

Quixada Acy,Filho Pedro Aurio Maia,Filho Tarcísio Paulo Almeida,Duarte Fernando Barroso,Moreira-Nunes Caroline Aquino,Lemes Romélia Pinheiro Gonçalves

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13256-016-0978-4.pdf

Reference13 articles.

1. Kantarjian HM, Deisseroth A, Kurzrock R, Estrov Z, Talpaz M. Chronic myelogenous leukemia: a concise update. Blood. 1993;82:691–703.

2. Nowell PC, Hungerford DA. A minute chromosome in human chronic granulocytic leucemia [letter]. Science. 1960;132:1497.

3. Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature. 1973;243:290–3.

4. Ben-Neriah Y, Daley GQ, Mes-Masson AM, Witte ON, Baltimore D. The chronic myelogenous leukemia-specific p210 protein is the product of the bcr/abl hybrid gene. Science. 1986;233:212–4.

5. Konopka JB, Witte ON. Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products. Mol Cell Biol. 1985;5:3116–23.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microbial tryptophan metabolites in cancer and leishmaniasis;Tryptamine Microbiota-Deregulated Aminoacyl-tRNA Biosynthesis;2024

2. Tyrosine-Kinase Inhibitors;Infectious Complications in Biologic and Targeted Therapies;2022

3. Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies;Clinical Microbiology Reviews;2020-06-17